Novel derivative of 'love hormone’ oxytocin improves cognitive impairment in Alzheimer’s

Alzheimer’s disease (AD), characterized by an accumulation of beta-amyloid protein in brain tissue, is a leading cause of dementia. Researchers now show that an oxytocin derivative with modifications to enhance brain perfusion can reverse cognitive impairment in mice.